您当前的位置:
首页 >
文章列表页 >
LC-MS-Based Metabonomics Study of Yangxin Tongmaifang Against Coronary Heart Disease Differentiated into Blood Stasis Syndrome
更新时间:2021-10-21
    • LC-MS-Based Metabonomics Study of Yangxin Tongmaifang Against Coronary Heart Disease Differentiated into Blood Stasis Syndrome

    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 27, Issue 22, Pages: 139-146(2021)
    • DOI:10.13422/j.cnki.syfjx.20211318    

      CLC: R285;R289;R22;R2-031;R33
    • Received:16 April 2021

      Published Online:23 September 2021

      Published:20 November 2021

    移动端阅览

  • ZHOU Man-li,YU Yun-feng,LUO Xiao-xin,et al.LC-MS-Based Metabonomics Study of Yangxin Tongmaifang Against Coronary Heart Disease Differentiated into Blood Stasis Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(22):139-146. DOI: 10.13422/j.cnki.syfjx.20211318.

  •  
  •  

0

Views

19

下载量

4

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Effect of Polysaccharides and n-Butanol Fractions of Atractylodis Rhizoma Stir-fried with Bran on Metabonomics in Rats with Spleen Deficiency
Research Progress in Treatment of Chemical Liver Injury with Chinese Medicine Based on Metabolomics
Pharmacological Effect and Toxicity of Xanthii Fructus
Extraction Technology Change and Pharmacological Test Verification of Tongmai Oral Liquid

Related Author

XU Huiying
DING Yihui
DONG Hao
ZHAO Xuecen
BAI Yang
CAI Qian
Yin-hua XIONG
Xi-lan TANG

Related Institution

College of Pharmacy, Liaoning University of Traditional Chinese Medicine
Jiangxi Provincial Key Laboratory of Drug Design and Evaluation,School of Pharmacy, Jiangxi Science and Technology Normal University
Guangxi University of Chinese Medicine
Shanghai University of Traditional Chinese Medicine
0